DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,610,830 | +18.2% | 34,464 | +18.1% | 2.20% | +71.9% |
Q1 2024 | $7,284,332 | +6.3% | 29,170 | -1.6% | 1.28% | -35.4% |
Q4 2023 | $6,855,067 | -6.9% | 29,632 | -0.2% | 1.98% | -15.9% |
Q3 2023 | $7,366,337 | +26.8% | 29,691 | +22.7% | 2.36% | +37.6% |
Q2 2023 | $5,808,000 | +89.5% | 24,200 | +99.0% | 1.71% | +81.4% |
Q1 2023 | $3,064,554 | +161.5% | 12,159 | +175.4% | 0.94% | +141.2% |
Q4 2022 | $1,171,829 | +125.3% | 4,415 | +119.2% | 0.39% | +117.2% |
Q3 2022 | $520,196 | +1.0% | 2,014 | -0.9% | 0.18% | +6.5% |
Q2 2022 | $515,153 | -5.7% | 2,032 | +9.1% | 0.17% | +12.7% |
Q1 2022 | $546,180 | -12.7% | 1,862 | -2.1% | 0.15% | -4.5% |
Q4 2021 | $625,777 | +14.7% | 1,902 | +6.1% | 0.16% | +9.0% |
Q3 2021 | $545,556 | +7.4% | 1,792 | -5.3% | 0.14% | +5.9% |
Q2 2021 | $507,737 | +3.6% | 1,892 | -13.1% | 0.14% | -11.7% |
Q1 2021 | $489,999 | – | 2,177 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |